---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-101405"
form_type: "8-K"
ticker: "AIDX"
cik: "0001139685"
company_name: "20/20 Biolabs, Inc."
filed_at: "2026-09-18T20:05:16+00:00"
generated_at: "2026-09-18T20:06:21.661208+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# 20/20 Biolabs shareholders approve 10x increase in authorized common stock to 500M shares

## Summary
- Shareholders approved charter amendment raising authorized common stock from 50 million to 500 million shares (10x increase).
- Vote totals: 3,028,609 for, 1,155,607 against, 72,621 abstentions at Sept 16 adjourned meeting.
- Annual meeting was adjourned Aug 18 after proposal lacked sufficient votes; quorum was met Sept 16.
- 4,256,837 shares represented (about 35% of 12,251,198 outstanding) constituted a quorum.

## SEC filing metadata
- accession: 0001213900-26-101405
- form_type: 8-K
- ticker: AIDX
- cik: 0001139685
- company_name: 20/20 Biolabs, Inc.
- filed_at: 2026-09-18T20:05:16+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1139685/000121390026101405/0001213900-26-101405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026101405/ea0305983-8k_2020bio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-101405
- JSON: https://secwatch.observer/filing/0001213900-26-101405.json
- Plain text: https://secwatch.observer/filing/0001213900-26-101405.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.